Not Just Skin-Deep: Psoriasis, Part IPremiere Date: Friday, February 27, 2015
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, February 27, 2016
Note: Credit Is No Longer Available
|April W. Armstrong, MD, MPH
Vice Chair of Clinical Research
Associate Professor of Dermatology
Director, Clinical Trials and Outcomes Research
Director, Psoriasis Program
Department of Dermatology
Colorado Health Outcomes Program
University of Colorado Denver, School of Medicine
|Alan Menter, MD
Chief, Division of Dermatology
Baylor Scott & White
Clinical Professor of Periodontics
Baylor College of Dentistry
Clinical Professor of Dermatology
University of Texas Southwestern Medical Center
Co-Chair, Psoriasis Guidelines Committee for the American Academy of Dermatology
A significant number of dermatologists are under-treating moderate-to-severe psoriasis despite the availability of effective agents and professional treatment guidelines. Patients with moderate-to-severe psoriasis are at risk for cardiovascular and psoriatic arthritis comorbidities and should be treated with systemic, combination agents to prevent cardiovascular and psoriatic arthritis complication.1,2
In this medical simulation, you will meet Lisa, a 45-year-old woman who presents to you feeling very self-conscious about her skin condition. Navigate this medical simulation and Lisa’s clinical challenges with Dr. Armstrong and Dr. Menter as your guides to improve your knowledge base and clinical management skills in patients with psoriasis.
After you have completed Part I, we encourage you to then check out Not Just Skin Deep: Psoriasis, Part II, to improve your knowledge of psoriasis comorbidities and clinical strategies to improve long-term patient outcomes.
Not Just Skin Deep: Psoriasis, Part I - Click the Begin Activity Now to get started.
Not Just Skin Deep: Psoriasis Part, II - Click here to access this activity
Parts I and II are each certified for 1.0 AMA PRA Category 1 Credit™. We encourage participants to complete both parts to optimize the learning experience and to gain valuable insights for treating patients with psoriasis.
- Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care of the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2008;58(5):826-850.
- Armstrong E, Harskamp C, Armstrong A. Psoriasis and major adverse cardiovascular events: a systemic review and meta-analysis of observational studies. J Am Heart Assoc. 2013;2(2):e000062.
Implement treatment according to treatment guidelines for more than 50% of my patients with psoriasis in the next three months.
At the end of this CE activity, participants should be able to:
- Implement treatment according to treatment guidelines in patients with moderate-to-severe psoriasis.
- Screen and counsel patients on comorbidities associated with psoriasis.
Supported by an educational grant from Celgene Corporation.
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
Dermatologists, primary care physicians, and other health care professionals, including pharmacists, nurses, physician assistants, and nurse practitioners, who have an interest in psoriasis.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hours.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-15-002-H01-P
Activity Type: application-based
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Armstrong has disclosed that she has received research and grant support from Amgen Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and Pfizer Inc. She serves as a consultant for AbbVie Inc.; Amgen Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.
Dr. Menter has no disclosures to report.
Erica Perilstein, MD (peer reviewer) has nothing to disclose.
Ruth Cody, MSN, RN-BC, CBN (peer reviewer) has nothing to disclose.
Frances Daniel, MPH (planning committee) has nothing to disclose.
Karen Roy, MSc., CCMEP (planning committee) has nothing to disclose.
Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).